GenomeNext Launches New SaaS Product that Offers Reproducible, Cost-Effective Variant Analysis, Annotation | GenomeWeb

NEW YORK (GenomeWeb) – GenomeNext has launched a new product for the next-generation sequencing market, a proprietary cloud-based data analysis pipeline that scientists in research and clinical contexts can use to process, analyze, and annotate variants in whole-genome, exome, and targeted panel data.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.